HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
Not recruitingEUCTR 2021-002108-11

A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated ...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Bulgaria · Croatia and 1 more location
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
355
Sponsor
Sunovion Pharmaceuticals Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Bulgaria, Croatia, Slovakia
Age range
Not clearly listed
Official registry ID
EUCTR 2021-002108-11
Official title
Show the full official title

A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated ...

Questions about this study?

The HopeStage team will email you.

Loading the security check...

Recruitment & locations

Not recruiting

Bulgaria · Croatia · Slovakia

Checked Official study record (opens in a new tab)
Registry details
Historical country statuses

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunovion Pharmaceuticals Inc.

Is this study still recruiting?

The historical registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me